Physician profile
Michael Proothi
NPI 1124279856
$888.99
in general payments reported to CMS, 2019-2025
11 companies · $58.84 in 2025
The $58.84 reported for 2025 was less than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $163 · 2021: $61.17 · 2022: $89.27 · 2023: $34.92 · 2024: $293 · 2025: $58.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $199.41 | 2019-2024 | |
| Stryker Corporation | $184.47 | 2021-2024 | Patient-Fitted Tmj Reconstructive Prosthesis System, Na, Vsp System, Vsp Cranial |
| Dentsply Sirona INC | $172.90 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $110.69 | 2019-2025 | |
| Geistlich Pharma, North America, INC. | $58.37 | 2019-2024 | Geistlich Bio-Gide |
| Nobel Biocare USA | $40.52 | 2021 | |
| Axogen | $30.69 | 2025 | |
| Kls-Martin L.P. | $29.57 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $26.11 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $21.31 | 2022 | |
| Depuy Synthes Sales INC. | $14.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Proothi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.